# | Title | Journal | Year | Citations |
---|
1 | Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes? | Journal of Alzheimer's Disease | 2005 | 1,445 |
2 | Alzheimer's Disease and the Amyloid-β Peptide | Journal of Alzheimer's Disease | 2010 | 1,270 |
3 | Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease | Journal of Alzheimer's Disease | 2017 | 1,123 |
4 | Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways | Journal of Alzheimer's Disease | 2008 | 835 |
5 | Religious Orders Study and Rush Memory and Aging Project | Journal of Alzheimer's Disease | 2018 | 731 |
6 | Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine | Journal of Alzheimer's Disease | 2005 | 631 |
7 | Role of Glutamate and NMDA Receptors in Alzheimer’s Disease | Journal of Alzheimer's Disease | 2017 | 627 |
8 | The Gut Microbiota and Alzheimer’s Disease | Journal of Alzheimer's Disease | 2017 | 624 |
9 | Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807 | Journal of Alzheimer's Disease | 2013 | 598 |
10 | The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade | Journal of Alzheimer's Disease | 2018 | 572 |
11 | Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2014 | 540 |
12 | Gut Microbiota is Altered in Patients with Alzheimer’s Disease | Journal of Alzheimer's Disease | 2018 | 538 |
13 | Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein | Journal of Alzheimer's Disease | 2001 | 504 |
14 | Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease | Journal of Alzheimer's Disease | 2018 | 500 |
15 | Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates | Journal of Alzheimer's Disease | 2014 | 493 |
16 | Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease | Journal of Alzheimer's Disease | 2005 | 492 |
17 | Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults | Journal of Alzheimer's Disease | 2008 | 477 |
18 | Apoptosis and Oxidative Stress in Neurodegenerative Diseases | Journal of Alzheimer's Disease | 2014 | 467 |
19 | Linguistic Features Identify Alzheimer’s Disease in Narrative Speech | Journal of Alzheimer's Disease | 2015 | 439 |
20 | Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models | Journal of Alzheimer's Disease | 2004 | 438 |
21 | The Many Substrates of Presenilin/γ-Secretase | Journal of Alzheimer's Disease | 2011 | 438 |
22 | The Alzheimer's Disease Mitochondrial Cascade Hypothesis | Journal of Alzheimer's Disease | 2010 | 435 |
23 | Microbes and Alzheimer’s Disease | Journal of Alzheimer's Disease | 2016 | 426 |
24 | Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal | Journal of Alzheimer's Disease | 2006 | 424 |
25 | Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808 | Journal of Alzheimer's Disease | 2013 | 418 |
26 | Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease | Journal of Alzheimer's Disease | 2006 | 415 |
27 | Determining the Presence of Periodontopathic Virulence Factors in Short-Term Postmortem Alzheimer's Disease Brain Tissue | Journal of Alzheimer's Disease | 2013 | 409 |
28 | Mitochondria-Targeted Antioxidants Protect Against Amyloid-β Toxicity in Alzheimer's Disease Neurons | Journal of Alzheimer's Disease | 2010 | 404 |
29 | Brain Reserve Hypothesis in Dementia | Journal of Alzheimer's Disease | 2007 | 391 |
30 | An In Vitro Model for Neuroscience: Differentiation of SH-SY5Y Cells into Cells with Morphological and Biochemical Characteristics of Mature Neurons | Journal of Alzheimer's Disease | 2010 | 387 |
31 | The Impact of General and Regional Anesthesia on the Incidence of Post-Operative Cognitive Dysfunction and Post-Operative Delirium: A Systematic Review with Meta-Analysis | Journal of Alzheimer's Disease | 2010 | 374 |
32 | Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia | Journal of Alzheimer's Disease | 2015 | 372 |
33 | Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2014 | 363 |
34 | A Phase II Trial of Tideglusib in Alzheimer's Disease | Journal of Alzheimer's Disease | 2015 | 363 |
35 | Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders | Journal of Alzheimer's Disease | 2006 | 362 |
36 | Caffeine and Adenosine | Journal of Alzheimer's Disease | 2010 | 360 |
37 | Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone | Journal of Alzheimer's Disease | 2010 | 359 |
38 | Why Women Have More Alzheimer's Disease Than Men: Gender and Mitochondrial Toxicity of Amyloid-β Peptide | Journal of Alzheimer's Disease | 2010 | 358 |
39 | Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment | Journal of Alzheimer's Disease | 2010 | 357 |
40 | Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study | Journal of Alzheimer's Disease | 2009 | 350 |
41 | Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis | Journal of Alzheimer's Disease | 2009 | 349 |
42 | PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses | Journal of Alzheimer's Disease | 2010 | 347 |
43 | Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options | Journal of Alzheimer's Disease | 2019 | 336 |
44 | Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β | Journal of Alzheimer's Disease | 2012 | 335 |
45 | GSK-3 is essential in the pathogenesis of Alzheimer's disease | Journal of Alzheimer's Disease | 2006 | 332 |
46 | Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges | Journal of Alzheimer's Disease | 2015 | 330 |
47 | Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction | Journal of Alzheimer's Disease | 2005 | 328 |
48 | Neurobiology of COVID-19 | Journal of Alzheimer's Disease | 2020 | 321 |
49 | Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment: A Field in Its Infancy | Journal of Alzheimer's Disease | 2010 | 319 |
50 | Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease | Journal of Alzheimer's Disease | 2017 | 319 |